PubRank

P Tassone

Author PubWeight™ 32.14‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 miR-29b sensitizes multiple myeloma cells to bortezomib-induced apoptosis through the activation of a feedback loop with the transcription factor Sp1. Cell Death Dis 2012 1.40
2 A unique three-dimensional SCID-polymeric scaffold (SCID-synth-hu) model for in vivo expansion of human primary multiple myeloma cells. Leukemia 2011 1.38
3 Pinna haematomas of the conchal bowl. Clin Otolaryngol 2007 1.37
4 Promises and challenges of MicroRNA-based treatment of multiple myeloma. Curr Cancer Drug Targets 2012 1.26
5 Antitumor therapeutic strategies based on the targeting of epidermal growth factor-induced survival pathways. Curr Drug Targets 2005 1.10
6 Telomerase inhibitor GRN163L inhibits myeloma cell growth in vitro and in vivo. Leukemia 2008 1.10
7 The eukaryotic initiation factor 5A is involved in the regulation of proliferation and apoptosis induced by interferon-alpha and EGF in human cancer cells. J Biochem 2003 1.09
8 Epstein-Barr virus nuclear antigen 2 transactivates the long terminal repeat of human immunodeficiency virus type 1. J Virol 1993 1.07
9 Evidence of a founder mutation of BRCA1 in a highly homogeneous population from southern Italy with breast/ovarian cancer. Hum Mutat 2001 1.01
10 The expression pattern of small nucleolar and small Cajal body-specific RNAs characterizes distinct molecular subtypes of multiple myeloma. Blood Cancer J 2012 1.00
11 Triggering of CD40 antigen inhibits fludarabine-induced apoptosis in B chronic lymphocytic leukemia cells. Blood 1998 0.96
12 NF-kappaB/Rel-mediated regulation of apoptosis in hematologic malignancies and normal hematopoietic progenitors. Leukemia 2004 0.94
13 EGF activates an inducible survival response via the RAS-> Erk-1/2 pathway to counteract interferon-alpha-mediated apoptosis in epidermoid cancer cells. Cell Death Differ 2003 0.89
14 Enhancement of cytosine arabinoside-induced apoptosis in human myeloblastic leukemia cells by NF-kappa B/Rel- specific decoy oligodeoxynucleotides. Gene Ther 2000 0.89
15 A 5' regulatory sequence containing two Ets motifs controls the expression of the Wiskott-Aldrich syndrome protein (WASP) gene in human hematopoietic cells. Blood 1998 0.89
16 ENT cases seen at a local 'walk-in centre': a one year review. J Laryngol Otol 2008 0.88
17 Cutting the limits of aminobisphosphonates: new strategies for the potentiation of their anti-tumour effects. Curr Cancer Drug Targets 2009 0.87
18 Amifostine inhibits hematopoietic progenitor cell apoptosis by activating NF-kappaB/Rel transcription factors. Blood 1999 0.86
19 Is acoustic analysis of snoring an alternative to sleep nasendoscopy? Clin Otolaryngol Allied Sci 2004 0.85
20 A new mutant of Arabidopsis disturbed in its roots, right-handed slanting, and gravitropism defines a gene that encodes a heat-shock factor. J Exp Bot 2008 0.85
21 Pegylated liposomal doxorubicin is active in Stewart-Treves syndrome. Ann Oncol 2007 0.82
22 Biological pathways and in vivo antitumor activity induced by Atiprimod in myeloma. Leukemia 2007 0.82
23 Synergistic induction of growth arrest and apoptosis of human myeloma cells by the IL-6 super-antagonist Sant7 and Dexamethasone. Cell Death Differ 2000 0.81
24 Regulation of NF-kappa B nuclear activity in peripheral blood mononuclear cells: role of CD28 antigen. Cell Immunol 1994 0.81
25 Targeting Raf-kinase: molecular rationales and translational issues. Ann Oncol 2006 0.81
26 Detection of microsatellite instability and loss of heterozygosity in serum DNA of small and non-small cell lung cancer patients: a tool for early diagnosis? Lung Cancer 2000 0.81
27 Transcriptional regulation of the mismatch repair gene hMLH1. Gene 2001 0.80
28 Defect of interleukin-2 production and T cell proliferation in atopic patients: restoring ability of the CD28-mediated activation pathway. Cell Immunol 1993 0.79
29 Partial purification and MALDI-TOF MS analysis of UN1, a tumor antigen membrane glycoprotein. Int J Biol Macromol 2006 0.79
30 Hereditary nonpolyposis coloretal cancer: identification of novel germline mutations in two kindreds not fulfulling the Amsterdam criteria. Mutations in brief no. 203. Online. Hum Mutat 1998 0.79
31 Identification by differential display of transcripts regulated during hematopoietic differentiation. Stem Cells 1998 0.78
32 Purification and characterization of a human sialoglycoprotein antigen expressed in immature thymocytes and fetal tissues. Tissue Antigens 1998 0.78
33 Surgical management of troublesome mastoid cavities. J Laryngol Otol 2010 0.77
34 Editorial: New approaches in the treatment of multiple myeloma: from target-based agents to the new era of microRNAs (dedicated to the memory of Prof. Salvatore Venuta). Curr Cancer Drug Targets 2012 0.76
35 A study of olfactory testing in patients with rhinological pathology in the ENT clinic. Rhinology 2008 0.75
36 Mycotic aneurysm of the external carotid artery. J Laryngol Otol 1998 0.75
37 T cell growth-promoting activity of interferon-gamma. Mitogenic effect of the recombinant cytokine on cells from a human T-chronic lymphocytic leukemia. Leukemia 1994 0.75
38 Randomised-controlled study comparing post-operative pain between coblation palatoplasty and laser palatoplasty. Clin Otolaryngol 2006 0.75
39 Anterior fracture dislocation of the odontoid peg in ankylosing spondylitis as a cause for rhinolalia clausa: a case study. J Laryngol Otol 2007 0.75
40 [Extended subcutaneous mastectomy. A new type of operation in non-destructive surgery of breast neoplasms]. Minerva Ginecol 1982 0.75
41 [Magnesium salts in the treatment of ventricular tachycardia]. G Ital Cardiol 1987 0.75
42 The 'Ic and Glic Pope Wick'. Clin Otolaryngol 2007 0.75
43 Difficult nasogastric intubation. Clin Otolaryngol 2007 0.75